Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Interest Expenses (2016 - 2025)

vTv Therapeutics (VTVT) has disclosed Interest Expenses for 11 consecutive years, with $1000.0 as the latest value for Q4 2025.

  • Quarterly Interest Expenses changed N/A to $1000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $6000.0 for FY2025, N/A changed from the prior year.
  • Interest Expenses hit $1000.0 in Q4 2025 for vTv Therapeutics, down from $5000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $8000.0 in Q3 2022 to a low of $1000.0 in Q1 2022.
  • Historically, Interest Expenses has averaged $4600.0 across 4 years, with a median of $5500.0 in 2021.
  • Biggest five-year swings in Interest Expenses: crashed 97.45% in 2021 and later soared 33.33% in 2022.
  • Year by year, Interest Expenses stood at $6000.0 in 2021, then changed by 0.0% to $6000.0 in 2022, then rose by 16.67% to $7000.0 in 2023, then plummeted by 85.71% to $1000.0 in 2025.
  • Business Quant data shows Interest Expenses for VTVT at $1000.0 in Q4 2025, $5000.0 in Q3 2025, and $7000.0 in Q4 2023.